Abstract: A method and data processing device for automatically generating a user-specific measuring data recording routine for discontinuous blood glucose measurement with a blood glucose measuring device in a data processing device. The method comprises the steps of providing of process data indicating an expected continuous course of the blood glucose value of a user, in the calculation unit based on blood glucose measuring values from continuous blood glucose measurement, generating of user-specific measuring routine data, which indicate a measuring routine with user-specific measuring events for discontinuous blood glucose measurement with a blood glucose meter taking into account the process data by means of the calculation unit, and providing of the user-specific measuring routine data to the data output interface for data transmission.

Abstract: A method and data processing device for automatically generating a user-specific measuring data recording routine for discontinuous blood glucose measurement with a blood glucose measuring device in a data processing device. The method comprises the steps of providing of process data indicating an expected continuous course of the blood glucose value of a user, in the calculation unit based on blood glucose measuring values from continuous blood glucose measurement, generating of user-specific measuring routine data, which indicate a measuring routine with user-specific measuring events for discontinuous blood glucose measurement with a blood glucose meter taking into account the process data by means of the calculation unit, and providing of the user-specific measuring routine data to the data output interface for data transmission.

Abstract: Methods for providing an estimated or predicted biological values in a sectioned display to assess the relative impact of a set of variables include collecting biological measurements, grouping the biological measurements based on the set of variables, evaluating the biological measurements to determine grouped estimated biological values or grouped predicted biological values, and providing the grouped estimated biological values or grouped predicted biological values within a plurality of sections in the sectioned display, wherein the plurality of sections correspond to the set of variables.

Abstract: Described are methods and devices for diagnosing heart failure in a subject based on the amount of brain natriuretic peptide (BNP) in a urine sample. Also described are methods and devices for predicting whether a subject is at risk of developing cardiovascular events accompanied with heart failure based on the amount of BNP in a urine sample.

Abstract: The present invention relates to diagnosing the risk of developing a need for dialysis and/or predicting a need for dialysis, particularly in patients suffering from renal disorders, comprising the steps of measuring the level of a BNP-type peptide or a variant thereof in a sample from the patient, diagnosing the risk by comparing the measured level of the BNP-type peptide or a variant thereof to at least one reference level. The BNP-type peptide may, for example, be brain natriuretic peptide (BNP), proBNP, NT-proBNP, a variant of BNP, a variant of proBNP, or a variant of NT-proBNP.

Abstract: The present invention relates to the diagnosis of the risk of experiencing a cardiovascular complication in the context of treatment with erythropoiesis stimulating agents (ESA's) such as erythropoietin and derivatives thereof particularly in the context of anemia. More particularly, the invention provides a method for diagnosing the risk of a patient of experiencing a cardiovascular complication as a consequence of future medication with an erythropoiesis stimulating agent (ESA), comprising the steps of (a) measuring the level of a BNP-type peptide in a sample of the patient, (b) diagnosing said risk by comparing the measured level of the BNP-type peptide to at least one reference level. The BNP-type peptide may for example be brain natriuretic peptide (BNP) or the N-terminal fragment of BNP, NT-proBNP. The cardiovascular complication may include complications, such as stroke, transient cerebral ischemic attack, acute-coronary syndrome, myocardial infarction, congestive heart failure etc.

Abstract: A method for the diagnosis of acute myocardial, ischaemic diseases, for example acute myocardial infarct, particularly without increasing ST-paths in EKG (NSTEMI). At least two markers on a patient, who is to examined, are determined. A kit for carrying out said diagnostic method, including a test strip for carrying out quick tests.